Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Neoplasms and CUL3[original query] |
|---|
| Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013 Jul 121 (7): 626-33. Kim Min S, Je Eun M, Oh Ji E, Yoo Nam J, Lee Sug |
| Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Feb 21 (3): 632-41. Seiwert Tanguy Y, Zuo Zhixiang, Keck Michaela K, Khattri Arun, Pedamallu Chandra S, Stricker Thomas, Brown Christopher, Pugh Trevor J, Stojanov Petar, Cho Juok, Lawrence Michael S, Getz Gad, Brägelmann Johannes, DeBoer Rebecca, Weichselbaum Ralph R, Langerman Alexander, Portugal Louis, Blair Elizabeth, Stenson Kerstin, Lingen Mark W, Cohen Ezra E W, Vokes Everett E, White Kevin P, Hammerman Peter |
| Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer. The Prostate 2014 Jun 74 (9): 983-90. Zuhlke Kimberly A, Johnson Anna M, Tomlins Scott A, Palanisamy Nallasivam, Carpten John D, Lange Ethan M, Isaacs William B, Cooney Kathleen |
| SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. Journal of experimental & clinical cancer research : CR 2018 7 37 (1): 145. Ma Jian, Chang Kun, Peng Jingtao, Shi Qing, Gan Hualei, Gao Kun, Feng Kai, Xu Fujiang, Zhang Hailiang, Dai Bo, Zhu Yao, Shi Guohai, Shen Yijun, Zhu Yiping, Qin Xiaojian, Li Yao, Zhang Pingzhao, Ye Dingwei, Wang Chen |
| The long tail of oncogenic drivers in prostate cancer. Nature genetics 2018 Apr . Armenia Joshua, Wankowicz Stephanie A M, Liu David, Gao Jianjiong, Kundra Ritika, Reznik Ed, Chatila Walid K, Chakravarty Debyani, Han G Celine, Coleman Ilsa, Montgomery Bruce, Pritchard Colin, Morrissey Colm, Barbieri Christopher E, Beltran Himisha, Sboner Andrea, Zafeiriou Zafeiris, Miranda Susana, Bielski Craig M, Penson Alexander V, Tolonen Charlotte, Huang Franklin W, Robinson Dan, Wu Yi Mi, Lonigro Robert, Garraway Levi A, Demichelis Francesca, Kantoff Philip W, Taplin Mary-Ellen, Abida Wassim, Taylor Barry S, Scher Howard I, Nelson Peter S, de Bono Johann S, Rubin Mark A, Sawyers Charles L, Chinnaiyan Arul M, , Schultz Nikolaus, Van Allen Eliezer |
| Variants in the 3'-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma. Journal of Cancer 2018 11 9 (20): 3647-3650. Hu Jin-Long, Hu Xin-Long, Lu Chuang-Xin, Chen Xue-Jiao, Fu Lei, Han Qian, Cang Shun-Do |
| Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2019 Aug 134 42-45. Hellyer Jessica A, Stehr Henning, Das Millie, Padda Sukhmani K, Ramchandran Kavitha, Neal Joel W, Diehn Maximilian, Wakelee Heather |
| Molecular subtype classification of papillary renal cell cancer using miRNA expression. OncoTargets and therapy 2019 12 2311-2322. Yu Changwen, Dai Danjing, Xie Ju |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
| Evaluation of cfDNA as an early detection assay for dense tissue breast cancer. Scientific reports 2022 May 12 (1): 8458. Barbirou Mouadh, Miller Amanda A, Gafni Erik, Mezlini Amel, Zidi Asma, Boley Nathan, Tonellato Peter |
| LZTR1 mutation mediates oncogenesis through stabilization of EGFR and AXL. Cancer discovery 2022 11 . Ko Aram, Hasanain Mohammad, Oh Young Taek, D'Angelo Fulvio, Sommer Danika, Frangaj Brulinda, Tran Suzanne, Bielle Franck, Pollo Bianca, Paterra Rosina, Mokhtari Karima, Soni Rajesh Kumar, Peyre Matthieu, Eoli Marica, Papi Laura, Kalamarides Michel, Sanson Marc, Iavarone Antonio, Lasorella An |
| A comparative analysis indicates SLC7A11 expression regulate the prognostic value of KEAP1-NFE2L2-CUL3 mutations in human uterine corpus endometrial carcinoma. Free radical biology & medicine 2024 6 . Akhileshwar Namani, Durgadevi Veeraiyan, Tapas Pat |
| Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, Michael B Major, Brittany J Holmes, Ngan K Nguyen, Parasakthy Kumaravelu, Tim Hodge, Maximilian Diehn, Jose P Zevallos, F Christopher Holsinger, Bahman Emami, Richard C Jordan, Michele C Hayward, Stephen M Sagar, William Morrison, Christopher Schultz, Jimmy J Caudell, Christopher U Jones, Scott V Bratman, Thomas J Galloway, Daniel J Ma, Sue S Yom, Mahesh Kudrimoti, Harold E Kim, Jonathan Harris, Quynh-Thu Le, D Neil Hay |
- Page last reviewed:Feb 1, 2024
- Content source: